Literature DB >> 1688545

Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases.

L D Truong1, M L Maccato, H Awalt, P T Cagle, M R Schwartz, A L Kaplan.   

Abstract

Serous surface carcinoma (SSC) of the peritoneum is defined as a primary tumor histologically indistinguishable from serous carcinoma of the ovary, diffusely involving the peritoneal surface but sparing or only superficially invading the ovaries. In this study of 22 cases of SSC, it was found that the main clinical manifestations of SSC were abdominal pain and enlargement. In most cases, SSC evenly involved the entire mesothelial surface but rarely was predominant in or even limited to the pelvis. It frequently invaded the submesothelium, but deep invasion into abdominal and pelvic organs or local metastasis was rare, and distant metastasis was not seen at presentation. Microscopically, SSC was a high-grade tumor frequently showing high mitotic rate, psammomas bodies, and necrosis. The tumor was usually contiguous with hyperplastic mesothelium on either ovarian surface or other locations. Tumor cells in all cases except one showed cytoplasmic or surface neutral or acidic mucin or both. Tumor cells stained positive for keratin (100% of cases), epithelial membrane antigen (100%), Leu-M1 (45%), B72.3 (85%), vimentin (35%), and carcinoembryonic antigen (25%). Electron microscopic studies of six cases showed epithelial differentiation in each. Seven patients (32%) were alive with no clinical disease at 3 to 31 months, one patient (4%) was alive with extensive local disease at 24 months, 11 patients (50%) died almost exclusively of local recurrence at 1 to 70 months, and three patients (14%) died of operative complications. It is concluded that SSC arises from peritoneal mesothelium but has epithelial phenotype. It can be morphologically differentiated from other conditions with similar laparotomy findings, such as malignant mesothelioma, benign papillary mesothelioma, cystic mesothelioma, and benign or borderline peritoneal serous tumors. The prognosis of SSC is poor, and most patients die of uncontrollable local disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688545     DOI: 10.1016/0046-8177(90)90081-f

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case.

Authors:  Emel Canbay; Haruaki Ishibashi; Shouzou Sako; Toshiyuki Kitai; Eisei Nishino; Masamitsu Hirano; Akiyoshi Mizumoto; Yoshio Endo; Shun-Ichiro Ogura; Yutaka Yonemura
Journal:  Surg Today       Date:  2013-02-23       Impact factor: 2.549

2.  Rare form of extraovarian primary peritoneal papillary serous carcinoma with solitary cystic lesion mimicking a liver tumor; report of a case.

Authors:  Yuji Iimuro; Koichiro Ohashi; Kazuhiro Suzumura; Seikan Hai; Shogo Tanaka; Ikuo Nakamura; Yuichi Kondo; Yasukane Asano; Toshihiro Okada; Tadamichi Hirano; Nobukazu Kuroda; Seiichi Hirota; Jiro Fujimoto
Journal:  Clin J Gastroenterol       Date:  2013-01-31

3.  Primary peritoneal serous papillary carcinoma presenting as a large mesenteric mass mistaken for ovarian cancer: a case of primary peritoneal carcinoma.

Authors:  Ji Woo Kim; Hwa Sun Lee; Kyu Sik Shin; Young Ho Gam; Kyung Don Baik
Journal:  Obstet Gynecol Sci       Date:  2015-05-19

4.  Malignant Mixed Mullerian Tumor of the Extra-genital Coelomic Epithelium: Report of Two Cases.

Authors:  Irene G Ibanez-Manlapaz; David Mc Coy; Vincent Vincent; Ulla Jo Ule
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

Review 5.  Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

Authors:  Murray Joseph Casey; Chhanda Bewtra
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.

Authors:  Teng Hou; Dongxia Liang; Jiehua He; Xu Chen; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

7.  [Systemic treatment of peritoneal metastases].

Authors:  D Arnold; F Lordick
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

8.  Clinical characteristics of primary peritoneal carcinoma.

Authors:  Sang Young Roh; Sook Hee Hong; Yoon Ho Ko; Tae Hee Kim; Myung Ah Lee; Byoung Yong Shim; Jae Ho Byun; In Sook Woo; Jin Hyoung Kang; Young Seon Hong; Kyung Shik Lee
Journal:  Cancer Res Treat       Date:  2007-06-30       Impact factor: 4.679

9.  Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III-IV Ovarian Serous Carcinoma.

Authors:  R Kawaguchi; Y Tanase; S Haruta; A Nagai; S Yoshida; N Furukawa; H Ooi; K Kobayashi
Journal:  Case Rep Oncol       Date:  2012-04-13

10.  Primary peritoneal adenocarcinoma causes pleural effusion.

Authors:  Mohammad Shameem; Jamal Akhtar; Ummul Baneen; Rakesh Bhargava; Zuber Ahmed; Prakhar Sharma; Nafees Ahmad Khan; Mohd Jaseem Hassan
Journal:  N Am J Med Sci       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.